Clinical pharmacokinetics of ranolazineJERLING, Markus.Clinical pharmacokinetics. 2006, Vol 45, Num 5, pp 469-491, issn 0312-5963, 23 p.Article

Evolving needs: treatment revolutionEuropean heart journal supplements. 2004, Vol 6, Num I, issn 1520-765X, 20 p.Conference Proceedings

Comparative efficacy of ranolazine versus atenolol for chronic angina pectorisROUSSEAU, Michel F; POULEUR, Hubert; COCCO, Giuseppe et al.The American journal of cardiology. 2005, Vol 95, Num 3, pp 311-316, issn 0002-9149, 6 p.Article

Ranolazine : a novel agent that improves dysfunctional sodium channelsPHAM, D. Q; MEHTA, M.International journal of clinical practice (Esher). 2007, Vol 61, Num 5, pp 864-872, issn 1368-5031, 9 p.Article

Clinical implications of inhibition of the late sodium current : ranolazineBASSAND, Jean-Pierre.European heart journal supplements. 2006, Vol 8, Num A, issn 1520-765X, A14-A19Conference Paper

Effect of Ranolazine on Left Ventricular Dyssynchrony in Patients With Coronary Artery DiseaseVENKATARAMAN, Rajesh; JI CHEN; GARCIA, Ernest V et al.The American journal of cardiology. 2012, Vol 110, Num 10, pp 1440-1445, issn 0002-9149, 6 p.Article

Inhibition of the late sodium current as a potential cardioprotective principle : effects of the late sodium current inhibitor ranolazineBELARDINELLI, L; SHRYOCK, J. C; FRASER, H et al.Heart. Supplement. 2006, Vol 92, Num 4, iv6-iv14Article

Heart Rate as a Therapeutic Target in Angina Pectoris : Stable Angina Pectoris: Novel Therapeutics InsightsANDROULAKIS, Emmanuel; TOUSOULIS, Dimitris; STEFANADIS, Christodoulos et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 9, pp 1562-1568, issn 1381-6128, 7 p.Article

Ranolazine Maintained Sinus Rhythm in a Patient with Refractory Symptomatic Atrial FibrillationSOSSALLA, Samuel; SOHNS, Christian; SEEGERS, Joachim et al.Cardiovascular therapeutics (Print). 2013, Vol 31, Num 5, pp 303-306, issn 1755-5914, 4 p.Article

Role of Late Sodium Channel Current Block in the Management of Atrial Fibrillation : The late sodium current in the Heart: Basic and Clinical AspectsBURASHNIKOV, Alexander; ANTZELEVITCH, Charles.Cardiovascular drugs and therapy. 2013, Vol 27, Num 1, pp 79-89, issn 0920-3206, 11 p.Article

Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysisSAVARESE, Gianluigi; ROSANO, Giuseppe; FIMIANI, Luigi et al.International journal of cardiology. 2013, Vol 169, Num 4, pp 262-270, issn 0167-5273, 9 p.Article

Costs and Clinical Outcomes Associated with Use of Ranolazine for Treatment of AnginaPHELPS, Charles E; BUYSMAN, Erin K; REY, Gabriel Gomez et al.Clinical therapeutics. 2012, Vol 34, Num 6, pp 1395-1407, issn 0149-2918, 13 p.Article

Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: II. Insights from a mathematical modelNESTERENKO, Vladislav V; ZYGMUNT, Andrew C; RAJAMANI, Sridharan et al.American journal of physiology. Heart and circulatory physiology. 2011, Vol 70, Num 4, issn 0363-6135, H1615-H1624Article

Suppression of Re-Entrant and Multifocal Ventricular Fibrillation by the Late Sodium Current Blocker RanolazineMORITA, Norishige; JONG HWAN LEE; YUANFANG XIE et al.Journal of the American College of Cardiology. 2011, Vol 57, Num 3, pp 366-375, issn 0735-1097, 10 p.Article

The Metabolic Treatment of Patients with Coronary Artery Disease : Effects on Quality of Life and Effort Angina : The Metabolic Treatment of Coronary Artery Disease and Heart FailureCESAR, L. A. M; GOWDAK, L. H; MANSUR, A. P et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 8, pp 841-849, issn 1381-6128, 9 p.Article

Ranolazine as a Cardioplegia Additive Improves Recovery of Diastolic Function in Isolated Rat HeartsHWANG, Hyosook; ARCIDI, Joseph M; HALE, Sharon L et al.Circulation (New York, N.Y.). 2009, Vol 120, Num 11, issn 0009-7322, S16-S21, SUP1Conference Paper

Gender Comparison of Efficacy and safety of Ranolazine for Chronic Angina pectoris in four randomized clinical trialsWENGER, Nanette K; CHAITMAN, Bernard; VETROVEC, George W et al.The American journal of cardiology. 2007, Vol 99, Num 1, pp 11-18, issn 0002-9149, 8 p.Article

Ischemic heart disease: Metabolic approaches to managementPAULY, Daniel F; PEPINE, Carl J.Clinical cardiology (Mahwah, NJ). 2004, Vol 27, Num 8, pp 439-441, issn 0160-9289, 3 p.Article

Ranolazine Treatment for Myocardial Infarction? Effects on the Development of Necrosis, Left Ventricular Function and Arrhythmias in Experimental ModelsHALE, Sharon L; KLONER, Robert A.Cardiovascular drugs and therapy. 2014, Vol 28, Num 5, pp 469-475, issn 0920-3206, 7 p.Article

A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary interventionPELLICCIA, Francesco; PASCERI, Vincenzo; MARAZZI, Giuseppe et al.The American heart journal. 2012, Vol 163, Num 6, pp 1019-1023, issn 0002-8703, 5 p.Article

Clinical Experience with Ranolazine in a Veteran Population with Chronic Stable AnginaREEDER, Don N; GILLETTE, Michael A; FRANCK, Andrew J et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 1, pp 42-50, issn 1060-0280, 9 p.Article

Comparison of Effectiveness of Ranolazine Plus Amiodarone Versus Amiodarone Alone for Conversion of Recent-Onset Atrial FibrillationFRAGAKIS, Nikolaos; KOSKINAS, Konstantinos C; KATRITSIS, Demosthenes G et al.The American journal of cardiology. 2012, Vol 110, Num 5, pp 673-677, issn 0002-9149, 5 p.Article

Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium SensitivityLOVELOCK, Joshua D; MONASKY, Michelle M; DEWAN ZENG et al.Circulation research. 2012, Vol 110, Num 6, pp 841-850, issn 0009-7330, 10 p.Article

Rate-Dependent Effects of Vernakalant in the Isolated Non-Remodeled Canine Left Atria Are Primarily Due to Block of the Sodium Channel: Comparison With Ranolazine and dI-SotalolBURASHNIKOV, Alexander; POURRIER, Marc; GIBSON, John K et al.Circulation. Arrhythmia and electrophysiology. 2012, Vol 5, Num 2, pp 400-408, issn 1941-3149, 9 p.Article

Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparationsSZEL, Tamás; KONCZ, Istvan; VARRO, András et al.European journal of pharmacology. 2011, Vol 662, Num 1-3, pp 31-39, issn 0014-2999, 9 p.Article